APA Alıntı

Wortman, B. G., Creutzberg, C. L., Putter, H., Jürgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., . . . Nout, R. A. (2018). Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: Improving patient selection for adjuvant therapy. Br J Cancer.

Chicago Stili Alıntı

Wortman, B. G., et al. "Ten-year Results of the PORTEC-2 Trial for High-intermediate Risk Endometrial Carcinoma: Improving Patient Selection for Adjuvant Therapy." Br J Cancer 2018.

MLA Alıntı

Wortman, B. G., et al. "Ten-year Results of the PORTEC-2 Trial for High-intermediate Risk Endometrial Carcinoma: Improving Patient Selection for Adjuvant Therapy." Br J Cancer 2018.